News
Pfizer exec Philip Dormitzer amid claims the COVID-19 vaccine announcement was delayed to avoid influencing the 2020 election ...
In a 3-0 decision, the 2nd U.S. Circuit Court of Appeals found disputed issues over the sincerity of Jeanette Diaz's ...
New York is part of a $335 million multistate settlement with a spin-off company of the pharmaceutical giant Pfizer for its role in the opioid epidemic over the last twenty years.
Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.43 third-quarter 2025 dividend on the ...
Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with ...
6don MSN
The FDA has updated its warnings about potential cardiac risks associated with Pfizer and Moderna COVID-19 vaccines, ...
Pfizer was founded in 1849 on Bartlett Street in Brooklyn. Login. Subscribe. News; Magazines. An Interactive Experience. Current Issue. April 1, 2025. View this Issue. ... The Pfizer/New York Story.
Developers secure $720M loan for NYC's largest office-to-residential conversion, turning former Pfizer HQ into 1,602-unit luxury apartments. ... New York Business Journal. May 19, 2025.
Hosted on MSN1mon
European Court of Justice: Ursula von der Leyen's Pfizer texts must be released to New York Times - MSNThe court said Matina Stevi, a journalist with The New York Times, requested access to all text messages between von der Leyen and Pfizer CEO Albert Bourla between Jan. 1, 2021, and May 11, 2022.
Pfizer jumps into cancer-treatment race with a $6 billion licensing deal with a China-based company, six months after Merck’s move for a lot less money.
Pfizer said a late-stage study of its Hympavzi hemophilia drug met its key goals in patients with the blood-clotting disorder who have inhibitors that can render some treatments ineffective.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results